JWH 302 is primarily used in research settings to study the effects of cannabinoid receptor activity. It acts as a synthetic cannabinoid, mimicking the effects of natural cannabinoids found in cannabis. Researchers utilize it to explore the binding affinity and functional activity at CB1 and CB2 receptors, which are part of the endocannabinoid system. This helps in understanding the physiological and psychological impacts of cannabinoid receptor modulation. Additionally, JWH 302 is employed in developing pharmacological models to investigate potential therapeutic applications, such as pain management, inflammation, and neurological disorders. Its use is strictly confined to laboratory environments due to its potent psychoactive properties and potential health risks.